Patient Monitoring Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Patient Monitoring Market Trends and Insights

Rise in Chronic-Disease Prevalence & Comorbidity Clusters

Cardiovascular diseases caused 17.9 million deaths in 2021, and the International Diabetes Federation projects 783 million adults living with diabetes by 2045, a 46% surge that will overwhelm episodic clinic care ^{[2]World Health Organization, “Cardiovascular Diseases Fact Sheet,” who.int}. Multiparameter hubs that simultaneously track glucose, blood pressure, and weight are therefore gaining favor over single-parameter devices. The CDC reported in 2024 that 6 in 10 U.S. adults have at least one chronic condition and 4 in 10 have two or more, underscoring demand for continuous surveillance outside hospitals. Value-based contracts penalizing readmissions are pushing providers to deploy post-discharge monitoring that flags decompensation early. As interoperability improves, integrated platforms are expected to crowd out legacy stand-alone monitors within the patient monitoring market. 

Accelerating Shift to Hospital-at-Home & Virtual Wards

CMS transitioned its Acute Hospital Care at Home waiver into a permanent pathway in 2025, covering 290 hospitals across 37 states. The United Kingdom scaled virtual wards to more than 10,000 beds by mid-2024, freeing acute-care capacity. Hospital-at-home models require rugged, patient-operated devices that can transmit vitals via cellular or satellite gateways without onsite clinicians. Philips and GE HealthCare now bundle monitors, connectivity, and managed triage into per-patient subscriptions, converting capital expenditure to operating expense. As reimbursement converges across payers, adoption is widening among mid-size community hospitals, thereby broadening the patient monitoring market footprint  

AI-Enabled Early-Warning Systems Lowering Adverse-Event Costs

Predictive analytics that flag sepsis, respiratory failure, or cardiac arrest six to twelve hours before deterioration lower ICU length of stay by up to two days, saving hospitals significant labor and bed-capacity costs. The FDA’s 2025 guidance on change-control plans now lets vendors update AI algorithms without fresh 510(k) submissions, speeding iteration.

Early movers such as Epic’s in-EHR sepsis model and GE HealthCare’s AI Command Center are demonstrating measurable ROI, encouraging chief financial officers to expand budgets for analytics modules. As hospital systems integrate bedside streams into unified dashboards, the patient monitoring market gains a data-layer moat that is difficult for new entrants to replicate. 

Reimbursement Expansion for Remote Physiologic Monitoring (RPM)

The January 2026 RPM code revisions slashed the minimum interaction time to 10–19 minutes and created a 2–15-day code that covers post-surgical surveillance, effectively doubling eligible beneficiaries in the United States. Germany’s DiGA pathway had listed more than 50 RPM apps by 2024, and Japan added remote COPD and heart-failure monitoring to its fee schedule in 2024. These decisions elevate RPM from a telehealth add-on to mainstream therapy management. Vendors that master payer contracting and prior authorization stand to capture an outsized share in the patient monitoring market. 

Escalating Cybersecurity Insurance Premiums for Connected Devices

FDA Section 524B rules, effective June 2025, now demand software bills of materials and threat-modeling for every networked device, increasing compliance spend and driving insurance carriers to hike healthcare cyber-premiums 15–25%. For a 500-bed hospital, annual coverage can reach USD 300,000, exceeding amortized hardware costs over a seven-year cycle. Smaller hospitals, lacking full-time security staff, either delay purchases or accept higher risk, curbing near-term orders in the patient monitoring market.

High Total-Cost-of-Ownership in Low-Resource Settings

Median public-health spend in sub-Saharan Africa is only USD 50 per capita, leaving scant budget for devices that require cellular data plans and cloud storage. Grant-funded pilots often fail when connectivity subsidies expire, creating monitor graveyards. Vendors are field-testing offline-capable units that sync intermittently over Wi-Fi, yet the loss of real-time alerting reduces clinical value. Unless tiered-pricing or donation programs mature, low-income regions will lag, trimming global patient monitoring market growth.

Segment Analysis

By Type: Services Outpace Hardware as Managed Triage Scales

Devices retained 83.1% of the patient monitoring market share in 2025, supported by large ICU and step-down installed bases. However, services revenue spanning installation, data integration, analytics, and managed triage is forecast to grow 9.53% from 2026 to 2031, outpacing the overall patient monitoring market by 2.5 percentage points. Hospital executives prefer subscription bundles that convert capital outlays into predictable operating costs, and vendors such as GE HealthCare and Philips now tie monthly fees to active-patient counts rather than hardware units.

Wearable and patch-based monitors are expanding fastest within hardware, propelled by over-the-counter CGMs like Dexcom Stelo and Abbott Libre Rio that address wellness and prediabetes segments. Remote hubs face commoditization as smartphones offer built-in Bluetooth and LTE, pushing value toward cloud analytics. Consequently, the patient monitoring market size for device-only contracts is expected to plateau, while as-a-service models capture incremental spend.

By Application: OTC CGMs Propel Diabetes & Metabolic Monitoring

Cardiology accounted for 18.2% of 2025 revenue, yet diabetes and metabolic solutions are projected to deliver the highest CAGR at 10.12% through 2031. FDA clearances for OTC CGMs removed prescription barriers, unlocking millions of prediabetic and wellness users and enlarging the patient monitoring market size for metabolic tracking. 

Respiratory monitoring is also rebounding as connected positive-airway-pressure devices stream adherence metrics to clinicians. Maternal-fetal devices such as Masimo Stork add mobility to labor monitoring, but remain niche. Neurology is evolving toward rapid-response wireless EEG systems that compress diagnosis time from hours to minutes, attracting emergency departments seeking throughput gains. As new use cases mature, application diversity will insulate the patient monitoring market against single-indication slowdowns.

By End-User: Home-Healthcare Providers Lead Growth Curve

Hospitals maintained 65.98% of revenue in 2025, leveraging capital budgets to deploy multiparameter monitors and AI command centers. Home-healthcare providers, however, are forecast to record an 11.21% CAGR from 2026 to 2031 as permanent hospital-at-home reimbursement scales nationally. Consumers now expect the same real-time oversight in their living rooms that they once received in step-down units, expanding the patient monitoring market across residential settings. 

Specialty clinics deploy implantable loop recorders and connected spirometers to manage larger patient panels remotely, while ambulatory surgery centers send post-operative monitoring kits home to avert complications. Long-term-care facilities remain underpenetrated due to reimbursement gaps, yet pilot programs in Singapore have cut emergency transfers by up to 40%. Once payers recognize these savings, adoption could surge, further diversifying end-user demand within the patient monitoring market.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America generated 41.2% of 2025 revenue, buoyed by CMS RPM reforms, Section 524B cybersecurity mandates, and a robust hospital-at-home infrastructure. The region’s high average selling prices and payer willingness to reimburse managed services underpin its outsized contribution to the patient monitoring market size.

Europe holds significant share, supported by Germany’s DiGA reimbursement pathway and the United Kingdom’s virtual-ward expansion. EU Medical Device Regulation enforcement raised compliance costs but improved post-market surveillance, reinforcing trust among clinicians. Despite macroeconomic pressures, statutory insurers continue to fund connected-care pilots, stabilizing demand.

Asia-Pacific is the growth engine, forecast to post a 10.99% CAGR from 2026 to 2031. China’s NMPA approved more than 50 AI-enabled monitors in 2024-2025, while India liberalized telemedicine and Japan expanded coverage for remote COPD and heart-failure monitoring. These policy shifts, coupled with aging demographics, enlarge the patient monitoring market across populous economies. Middle East and Africa remain early-stage, yet Gulf Cooperation Council investments in smart hospitals are expected to seed future demand. South America shows selective uptake, led by private payers in Brazil.